Watch Ticker

Sutro Biopharma, Inc.

Go to Sutro Biopharma, Inc. Website

$0.81

0.00 (0.00%)

Live

Previous Close

$0.813

Day Range

$0 - $0

Previous Day Range

$0.8 - $0.8605

Market Cap

$69.9 million USD

Day Vol.

Previous Day Vol.

346898

Currency

USD

Primary Exchange

Nasdaq

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoim...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty

The article discusses the rise in cancer incidence and the need for better treatments, as well as the potential impact of budget reductions and new tariffs on innovation. Several oncology companies, including Oncolytics Biotech, Sutro Biopharma, BriaCell Therapeutics, and Tempus AI, have reported notable updates in 2025.

Related tickers: ONCY, STRO, BCTX, BCTXW, BCTXZ, TEM, AZN.

Read Full Article

Sutro Biopharma, Inc. - Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025

Sutro Biopharma presented data from the dose-optimization portion of the REFRαME-O1 trial for luveltamab tazevibulin (luvelta) in patients with platinum resistant ovarian cancer. The data showed encouraging antitumor activity and a consistent safety profile across dose levels.

Related tickers: STRO.

Read Full Article

Trending Tickers

Please sign in to view